Gene-IT Announces GenomeQuest™ Adoption by Biogen Idec

Leader in biological sequence search provides flagship IP solution to global leader in novel therapeutics

Westborough, Massachusetts – September 27, 2006 – Gene-IT, a leader in biological sequence search for research and IP, today announced that it is providing its flagship GenomeQuest™ service to Biogen Idec (NASDAQ: BIIB), a global biotechnology company with leading products and capabilities in oncology, neurology and immunology.

GenomeQuest is a biological sequence search solution that enables biologists to evaluate novel gene sequences, and allows IP lawyers to evaluate freedom-to-operate, patentability, and competitive landscape features for the same sequences. The solution uniquely combines easy-to-use sequence search and analytics with public and proprietary sequence content, including the industry’s largest and most complete indexed archive of more than 30 million patented sequences.

Ronald Ranauro, CEO of Gene-IT, said, “We are delighted that Biogen Idec has selected GenomeQuest as part of its patent search solution. The adoption of GenomeQuest by a worldwide leader and innovator such as Biogen Idec is further confirmation of our eminence as the leading solution provider for IP sequence search.”